Fortis Healthcare DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.79×	0.79×	0.81×	0.76×	0.80×
	0.82×	0.83×	0.83×	0.92×	1.01×
	17.5%	17.9%	15.4%	13.4%	12.5%
	0.62×	0.62×	0.58×	0.54×	0.52×
	1.57×	1.57×	1.49×	1.55×	1.53×
	11.0%	11.3%	9.0%	7.9%	8.0%
	11.1%	11.1%	9.3%	8.0%	8.8%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

FORTIS₹754.90

Fortis Healthcare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH MEDANTA AUROPHARMA LUPIN ALKEM LAURUSLABS MANKINDMcap ₹56,992 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.80	0.76	0.81	0.79	0.79
Interest Burden (Pretax/EBIT) ×	1.01	0.92	0.83	0.83	0.82
EBIT Margin %	12.47	13.42	15.45	17.92	17.48
Asset Turnover ×	0.52	0.54	0.58	0.62	0.62
Financial Leverage (Assets/Equity) ×	1.53	1.55	1.49	1.57	1.57
ROE (5-step product, year-end total equity) %	8.02	7.85	9.01	11.35	10.96
ROE (owners' profit / average owners' equity) %	8.77	8.04	9.34	11.08	11.08

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.